Quercetin inhibits IL-1β-induced inflammation, hyaluronan production and adipogenesis in orbital fibroblasts from graves' orbitopathy

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Yoon, Jin Sook ^a   Lee, Hyun Jung ^a   Choi, Soo Hyun ^a   Chang, Eun Ju ^b   Lee, Sang Yeul ^a   Lee, Eun Jig ^a  

^a Yonsei University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CYCLOOXYGENASE 2; FAT DROPLET; HYALURONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; Q 0125; QUERCETIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; TRANSCRIPTION FACTOR;

ADIPOGENESIS; ADIPOSE TISSUE; ADULT; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYCLOOXYGENASE 2 GENE; DRUG EFFECT; DRUG MECHANISM; ENDOCRINE OPHTHALMOPATHY; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST CULTURE; GENE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INTERCELLULAR ADHESION MOLECULE 1 GENE; INTERLEUKIN 6 GENE; INTERLEUKIN 8 GENE; MALE; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; BIOSYNTHESIS; CYTOLOGY; DRUG ANTAGONISM; GENETICS; GRAVES DISEASE; INFLAMMATION; METABOLISM; ORBIT; PATHOLOGY; PHYSIOLOGY;

ADIPOGENESIS; GRAVES DISEASE; HUMANS; HYALURONIC ACID; INFLAMMATION; INTERLEUKIN-1BETA; NF-KAPPA B; ORBIT; QUERCETIN; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 80054776633     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026261     Document Type: Article

References (35)

1. Garrity JA, Bahn RS, (2006) Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment. Am J Ophthalmol 142: 147-153.
2. Kuriyan AE, Phipps RP, Feldon SE, (2008) The eye and thyroid disease. Curr Opin Ophthalmol 19: 499-506.
3. Lehmann GM, Feldon SE, Smith TJ, Phipps RP, (2008) Immune mechanisms in thyroid eye disease. Thyroid 18: 959-965.
4. Sorisky A, Pardasani D, Gagnon A, Smith TJ, (1996) Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture. J Clin Endocrinol Metab 81: 3428-3431.
5. Crisp M, Starkey KJ, Lane C, Ham J, Ludgate M, (2000) Adipogenesis in thyroid eye disease. Invest Ophthalmol Vis Sci 41: 3249-3255.
6. Bartalena L, Pinchera A, Marcocci C, (2000) Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev 21: 168-199.
7. Ong CS, Tran E, Nguyen TT, Ong CK, Lee SK, et al. (2004) Quercetin-induced growth inhibition and cell death in nasopharyngeal carcinoma cells are associated with increase in Bad and hypophosphorylated retinoblastoma expressions. Oncol Rep 11: 727-733.
8. Mertens-Talcott SU, Talcott ST, Percival SS, (2003) Low concentrations of quercetin and ellagic acid synergistically influence proliferation, cytotoxicity and apoptosis in MOLT-4 human leukemia cells. J Nutr 133: 2669-2674.
9. Kawada N, Seki S, Inoue M, Kuroki T, (1998) Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology 27: 1265-1274.
10. Comalada M, Camuesco D, Sierra S, Ballester I, Xaus J, et al. (2005) In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. Eur J Immunol 35: 584-592.
11. Ying B, Yang T, Song X, Hu X, Fan H, et al. (2009) Quercetin inhibits IL-1 beta-induced ICAM-1 expression in pulmonary epithelial cell line A549 through the MAPK pathways. Mol Biol Rep 36: 1825-1832.
12. Park HJ, Yang JY, Ambati S, Della-Fera MA, Hausman DB, et al. (2008) Combined effects of genistein, quercetin, and resveratrol in human and 3T3-L1 adipocytes. J Med Food 11: 773-783.
13. Ahn J, Lee H, Kim S, Park J, Ha T, (2008) The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem Biophys Res Commun 373: 545-549.
14. Visentin V, Prevot D, Marti L, Carpene C, (2003) Inhibition of rat fat cell lipolysis by monoamine oxidase and semicarbazide-sensitive amine oxidase substrates. Eur J Pharmacol 466: 235-243.
15. Lisi S, Botta R, Lemmi M, Sellari-Franceschini S, Altea MA, et al. (2011) Quercetin Decreases Proliferation of Orbital Fibroblasts and Their Release of Hyaluronic Acid. J Endocrinol Invest 34: 521-527.
16. Cawood TJ, Moriarty P, O'Farrelly C, O'Shea D, (2007) Smoking and thyroid-associated ophthalmopathy: A novel explanation of the biological link. J Clin Endocrinol Metab 92: 59-64.
17. Pritchard J, Horst N, Cruikshank W, Smith TJ, (2002) Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts. Journal of immunology 168: 942-950.
18. Zhao LQ, Wei RL, Cheng JW, Cai JP, Li Y, (2010) The expression of intercellular adhesion molecule-1 induced by CD40-CD40L ligand signaling in orbital fibroblasts in patients with Graves' ophthalmopathy. Invest Ophthalmol Vis Sci 51: 4652-4660.
19. Heufelder AE, Bahn RS, (1992) Graves' immunoglobulins and cytokines stimulate the expression of intercellular adhesion molecule-1 (ICAM-1) in cultured Graves' orbital fibroblasts. Eur J Clin Invest 22: 529-537.
20. Hiromatsu Y, Yang D, Bednarczuk T, Miyake I, Nonaka K, et al. (2000) Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 85: 1194-1199.
21. Hwang CJ, Afifiyan N, Sand D, Naik V, Said J, et al. (2009) Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1. Invest Ophthalmol Vis Sci 50: 2262-2268.
22. Chen B, Tsui S, Smith TJ, (2005) IL-1 beta induces IL-6 expression in human orbital fibroblasts: identification of an anatomic-site specific phenotypic attribute relevant to thyroid-associated ophthalmopathy. J Immunol 175: 1310-1319.
23. Burnstine MA, Elner SG, Elner VM, (1998) Orbital fibroblast chemokine modulation: effects of dexamethasone and cyclosporin A. Br J Ophthalmol 82: 318-322.
24. Wakelkamp IM, Bakker O, Baldeschi L, Wiersinga WM, Prummel MF, (2003) TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. Clin Endocrinol (Oxf) 58: 280-287.
25. Cao HJ, Wang HS, Zhang Y, Lin HY, Phipps RP, et al. (1998) Activation of human orbital fibroblasts through CD40 engagement results in a dramatic induction of hyaluronan synthesis and prostaglandin endoperoxide H synthase-2 expression. Insights into potential pathogenic mechanisms of thyroid-associated ophthalmopathy. J Biol Chem 273: 29615-29625.
26. Feldon SE, O'Loughlin CW, Ray DM, Landskroner-Eiger S, Seweryniak KE, et al. (2006) Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes. Am J Pathol 169: 1183-1193.
27. Bahn RS, Heufelder AE, (1993) Pathogenesis of Graves' ophthalmopathy. N Engl J Med 329: 1468-1475.
28. Kaback LA, Smith TJ, (1999) Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1beta in human orbital fibroblasts: potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 84: 4079-4084.
29. Smith TJ, Wang HS, Evans CH, (1995) Leukoregulin is a potent inducer of hyaluronan synthesis in cultured human orbital fibroblasts. Am J Physiol 268: C382-388.
30. Rayalam S, Yang JY, Ambati S, Della-Fera MA, Baile CA, (2008) Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes. Phytother Res 22: 1367-1371.
31. Zieleniak A, Wojcik M, Wozniak LA, (2008) Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma. Arch Immunol Ther Exp (Warsz) 56: 331-345.
32. Kuppusamy UR, Das NP, (1994) Potentiation of beta-adrenoceptor agonist-mediated lipolysis by quercetin and fisetin in isolated rat adipocytes. Biochem Pharmacol 47: 521-529.
33. Cawood TJ, Moriarty P, O'Farrelly C, O'Shea D, (2006) The effects of tumour necrosis factor-alpha and interleukin1 on an in vitro model of thyroid-associated ophthalmopathy; contrasting effects on adipogenesis. Eur J Endocrinol 155: 395-403.
34. Bischoff SC, (2008) Quercetin: potentials in the prevention and therapy of disease. Curr Opin Clin Nutr Metab Care 11: 733-740.
35. Green H, Kehinde O, (1975) An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 5: 19-27.